Experimental work to create one new vaccine against Omicron mutation It will not take more than 10 days, said the director of the Gamalei Research Center for Epidemiology and Microbiology in Moscow, which developed the Russian Sputnik-V vaccine against coronavirus, Alexander Ginsburg, speaking to Russia-24 television channel.
“The experimental work to obtain a new vaccine against the Omicron strain will not take more than 10 days. The rest of the time is spent on regulatory procedures. That is, processes related to licensing and the documentation that this vaccine is safe “, said Ginsburg, according to the TASS agency.
Given these procedures, the approval of the vaccine against the Omicron variant by the Ministry of Health of Russia it may take 45-50 days, he estimated.
Sputnik may provide protection against variation
Earlier, Russia announced that its vaccine, developed by the Gamale Institute of Moscow, Sputnik-V is likely to provide protection against the Omicron variant, as broadcast by ΑΠΕ ΜΠΕ.
“The Gamale Institute believes that Sputnik V and Sputnik-Light will neutralize the Omicron variant, as they have the highest efficacy against other mutations,” he said. Kirill Dmitriev, head of the Russian Direct Investment Fund (RDIF), which trades the vaccine abroad through Sputnik-V’s official Twitter account.
“In the unlikely event that modification is required, we will produce several hundred million Sputnik booster vaccines adapted to the new variant until February 20, 2022 “, he stated.
Earlier, the Kremlin said more data was needed before conclusions could be drawn on the new coronavirus variant. “We see that the reaction to the markets is extremely emotional, it is not based on any scientific evidence, because it simply does not exist yet,” a Kremlin spokesman told reporters. Dmitry Peshkov.
RDIF & Gamaleya Institute on #Omicron variant of COVID: “Sputnik V and Light are expected to neutralize Omicron as other mutations, necessary studies started. In unlikely case modification is needed, Sputnik Omicron will go in production in 45 days.”
👇https://t.co/zeXMdWLqzD– Sputnik V (@sputnikvaccine) November 29, 2021

Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.